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US features, each thyroid nodule can be tentatively classified 
as: malignant, suspicious for malignancy, borderline, prob-
ably benign, and benign.  Conclusions: We propose a stan-
dardized US report and a tentative US classification system 
that may become helpful for endocrinologists dealing with 
thyroid nodules in their clinical practice. The proposed clas-
sification does not allow to bypass the required cytological 
confirmation, but may become useful in identifying the le-
sions with a lower risk of neoplasm.
 Copyright © 2013 European Thyroid Association
 Published by S. Karger AG, Basel
 Introduction
 Nodular thyroid disease is a common finding, espe-
cially in females and in the elderly population. Thyroid 
nodules are found in 5% of the general population with 
the use of palpation  [1] , but high-resolution ultrasonog-
raphy (US) allows their detections in up to 67% of sub-
jects  [2] and the number of discovered thyroid nodules
is increasing over time. Malignancy comprises approxi-
mately 5% of all thyroid nodules  [3] and its incidence is 
increasing all over the world in recent years  [4] . There-
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 Abstract
 Background: Ultrasonography (US) plays a crucial role in the 
diagnostic management of thyroid nodules, but its wide-
spread use in clinical practice might generate heterogeneity 
in ultrasound reports.  Objectives: The aims of the study were 
to propose (a) a standardized lexicon for description of thy-
roid nodules in order to reduce US reports of interobserver 
variability and (b) a US classification system of suspicion for 
thyroid nodules in order to promote a uniform management 
of thyroid nodules.  Methods: Relevant published articles 
were identified by searching MEDLINE at PubMed combin-
ing the following search terms: ultrasonography, thyroid, 
nodule, malignancy, carcinoma, and classification system. 
Results were supplemented with our data and experience. 
 Results: A standardized US report should always document 
position, extracapsular relationships, number, and the fol-
lowing characteristics of each thyroid lesion: shape, internal 
content, echogenicity, echotexture, presence of calcifica-
tions, margins, vascularity, and size. Combining the previous 
 Received: November 27, 2012
 Accepted after revision: January 14, 2013
 Published online: February 23, 2013 
 Massimiliano Andrioli, MD, PhD or Luca Persani, MD, PhD
 Ospedale San Luca, IRCCS
 Istituto Auxologico Italiano, P. le Brescia 20
 IT–20149 Milan (Italy)
 E-Mail massimoandrioli   @   endocrinologiaoggi.it or luca.persani@unimi.it 
 © 2013 European Thyroid Association 
 Published by S. Karger AG, Basel 
 2235–0640/13/0021–0037$38.00/0 
 www.karger.com/etj 
 Andrioli  /Carzaniga  /Persani  
 
Eur Thyroid J 2013;2:37–48 
 DOI: 10.1159/000347144 
38
fore, the correct identification of nodules that are malig-
nant and avoidance of unnecessary procedures for those 
that are benign represent the challenge for endocrinolo-
gists.
 Cytological examination of material obtained by fine-
needle cytology (FNC), due to its high sensitivity and 
specificity, is still the best single test for differentiating 
benign from malignant thyroid lesions  [5] . However, 
there is a recognized 5% false-negative rate  [6] and, as 
compared with thyroid US, FNC has the disadvantage of 
being an invasive procedure. Moreover, thyroid US gives 
immediate information about the degree of suspicion of 
thyroid lesions. Originally, thyroid US was used almost 
exclusively to differentiate between the cystic and solid 
nature of thyroid lesions and to measure their size  [7] . 
Afterwards, it was suggested that US could help identify 
characteristics suspicious for malignancy of thyroid tis-
sue  [8] , and only recently, thyroid US has been widely 
recognized as the first-line diagnostic procedure for char-
acterizing thyroid lesions  [9] .
 Many studies had focused on how US can help distin-
guish benign and malignant lesions, and different guide-
lines and recommendations for the US management of 
thyroid nodules were proposed by different organizations 
 [10, 11] . Unfortunately, even if there is an agreement on 
the central role of US in nodule work-up, there has been 
no universal consensus on a standardized terminology 
for thyroid US.
 The need of uniform and standardized US reports is 
nowadays even greater due to the large number of physi-
cians who perform thyroid US. In fact, with increased ac-
cessibility of high-resolution, portable US machines, thy-
roid US is being performed more commonly by non-ra-
diologist physicians, e.g. surgeons, general physicians, 
and most of all endocrinologists. The latter, with their 
extensive knowledge about thyroid physiology and patho-
physiology, are ideally suited to becoming more skilled in 
the use of thyroid US.
 Therefore, this work is addressed to skilled physicians 
(endocrinologists and/or US operators) working in high-
ly specialized centers for the management of thyroid nod-
ules and was aimed to: (a) propose a universal standard-
ized terminology for the description of thyroid nodules; 
(b) reduce US report variability between endocrinologists 
performing thyroid US; (c) provide endocrinologists not 
directly performing US, the needed terminology back-
ground for a correct interpretation and management of 
US reports, and (d) propose a US classification system of 
suspicion for thyroid malignancy to be validated in a pro-
spective trial.
 Methods
 A literature search of English language journal articles in the 
MEDLINE database (PubMed) was undertaken. Search terms in-
cluded: ultrasonography, thyroid, nodule, malignancy, carcinoma, 
and classification system. Consensus statements and recommen-
dations for the US management of thyroid nodules, based on re-
view of evidence and expert opinions, were also reviewed. We sup-
plemented the search with records from personal files and our ex-
perience.
 US Definition and Description of Thyroid Nodule
 The echotexture of the normal thyroid is usually ho-
mogeneous and bright. A thyroid nodule is defined as a 
discrete lesion within the thyroid gland that is ultrasono-
graphically distinct from the surrounding thyroid paren-
chyma  [12] . A nodule usually differs from a pseudonod-
ule for being always clearly distinguishable in both trans-
verse and longitudinal planes.
 In our opinion, a standardized and systematic descrip-
tion of US features of thyroid lesions makes the reports 
objective and more comparable over time. Moreover, a 
systematic report reduces the possibility of missing the 
description of some important thyroid lesions features. 
Therefore, if possible, US reports should always docu-
ment position, extracapsular relationships, number and 
the following characteristics of each lesion: shape, inter-
nal content, echogenicity, echotexture, presence of calci-
fications, margins, vascularity, hardness, and size.
 Position
 The exact location of each nodule within the thyroid 
gland should always be described in US reports. Thyroid 
US usually permits a clear identification of an isthmus 
and of two lobes. Schematically, each thyroid lobe can be 
virtually divided into three portions: one  third superior , 
one  third medium , one  third inferior and each portion can 
be further subdivided into two sub-portions:  anterior and 
 posterior . Isthmus can be divided into:  right parahistmic , 
 left parahistmic and  central part . Any thyroid lesion can 
be described as approximately located in one of these sec-
tions. Seldom, thyroid nodules are located in the pyra-
midal lobe and more rarely they can be ectopic. Careful 
attention should be placed on nodules placed near the 
thyroid capsule. In this case, description of possible de-
formation or infiltration of the hyperechoic thyroid cap-
sule and of invasion of adjacent structures is always rec-
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ommended (see Extracapsular Relationships). Nodules 
localized in the posterior part of the two thirds inferior of 
thyroid lobes, close to the thyroid capsule, should be dif-
ferentiated from parathyroid adenomas.
 The systematic description of the thyroid nodule posi-
tion is useful exclusively in monitoring the lesion during 
the follow-up. In fact, although medullary thyroid carci-
noma is more frequently placed between the one third 
superior and the two thirds inferior of thyroid lobes  [13] , 
the localization of a thyroid lesion has no diagnostic im-
portance in distinguishing between benign and malig-
nant nodules.
 Extracapsular Relationships
 Extracapsular relationships of nodules placed near the 
thyroid capsule should be carefully described. Operators 
should observe whether the nodule deforms, infiltrates or 
even crosses the thyroid capsule invading the nearby 
structures. Therefore, it is important to distinguish sim-
ple  deformation from  infiltration of thyroid capsule, and 
to describe a possible  invasion of the extracapsular areas 
for a presurgical US tumor staging (T of TNM) of thyroid 
cancer.
 The thyroid capsule may be simply deformed by nod-
ules without interruption of its hyperechogenicity 
( fig. 1 .1). Deformation of the capsule does not indicate 
malignancy but it can be useful in assessing possible com-
pression of adjacent structures. Infiltration of the thyroid 
capsule, instead, is defined as an interruption of its hyper-
echogenicity at the level of the tumor ( fig. 1 .2). This find-
ing is always indicative of malignancy but does not neces-
sarily mean an invasion of surrounding structures. In our 
experience, in fact, a clear US interruption of the capsule 
does not always correspond to extrathyroidal extension 
(T3) at postsurgical histological evaluation, indicating 
that US probably may overestimate tumor staging (T) in 
the TNM classification. Finally, invasion of the adjacent 
structures by invasive thyroid cancers is observed only 
occasionally ( fig. 1 .3). In these cases, the thyroid capsule 
is not only interrupted at the level of the tumor, but tu-
moral tissue is seen to penetrate into surrounding strap 
muscles or into close structures, e.g. trachea, esophagus, 
thyroid cartilage, and jugular vein. Extracapsular exten-
sion more frequently identified anaplastic carcinomas, 
thyroid lymphomas or intrathyroidal metastasis. On the 
contrary, extracapsular extension is less common in dif-
ferentiated thyroid carcinoma in which associated meta-
static lymphadenopathy is the most frequent finding  [14] .
 Number
 Thyroid goiters may contain several nodules and in 
clinical practice endocrinologists often wonder if listing 
and describing all thyroid nodules, even those most likely 
benign, is really always necessary. It has been shown that 
the risk of malignancy in a multinodular thyroid gland 
compared to a gland with a solitary thyroid nodule is sim-
ilar  [3] . It follows that careful attention should be placed 
on all discovered thyroid nodules. Therefore, ideally, each 
nodule should be listed and analytically described. In 
clinical practice, instead, two exceptions may be granted 
when several thyroid lesions are present. First, when there 
are coalescent thyroid lesions not clearly distinguishable 
and a detailed characterization of each nodule is impos-
sible to perform. Second, in case of clearly distinguishable 
thyroid lesions, with benign or probably benign features, 
when a detailed description of all nodules can result wea-
risome or may divert from more suspicious lesions. In 
these cases we suggest endocrinologists performing US to 
particularly focus their attention on lesions classifiable as 
malignant, suspicious for malignancy or borderline (see 
below) that should always be described in detail. The re-
maining lesions classifiable as benign or probably benign 
(see below) should be only listed indicating exclusively 
their position and size, but avoiding their overdetailed 
description. This approach is aimed to obtain clear and 
streamlined reports but containing all the information on 
the most suspicious lesions. In all other situations, a care-
ful notation and description of each thyroid nodule is al-
ways recommended.
 Shape
 The shape of a nodule has gained diagnostic impor-
tance for the differentiation of benign and malignant 
nodules only recently  [15] . Based on their shape, thyroid 
nodules can be classified as:  ovoid (when the anteropos-
terior diameter of a nodule is less than its transverse di-
ameter on a transverse or longitudinal plane) ( fig. 1 .1), 
r ound (when the anteroposterior diameter of a nodule is 
equal to its transverse diameter on a transverse or longi-
tudinal plane) ( fig. 1 .4),  taller-than-wide (when the an-
teroposterior diameter of a nodule is longer than its trans-
verse diameter on a transverse or longitudinal plane) 
( fig.  1 .5) or  irregular (when a nodule is neither ovoid/
round nor taller-than-wide) ( fig. 1 .6).
 Both ovoid shape and round shape are reported in be-
nign lesions but they do not obviously exclude malignan-
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cy. Instead, a taller-than-wide shape, although in which 
plane the ratio should be calculated is still a matter of de-
bate, is reported to be associated with thyroid malignancy 
 [15–17] . These findings reflect that malignant nodules 
grow across the normal tissue plane in a centrifugal and 
antigravitational way, in contrast to benign nodules usu-
ally growing along the tissue plane in a parallel fashion 
 [15, 18, 19] . A nodule with irregular shape may be a ma-
lignant lesion, but irregular shape can also be noticed in 
benign conditions, such as focal thyroiditis  [20] .
 Internal Content
 Usually, internal content of thyroid nodules can be 
easily detected by US and it should always be reported 
because it is generally helpful in their differential diagno-
sis. The internal content of thyroid nodules can be classi-
fied following terminology based on the ratio of the cystic 
portion to the solid portion of the lesion:  solid (liquid por-
tion  ≤ 10% of the nodule volume) ( fig. 1 .7),  mixed pre-
dominantly solid (liquid portion >10% but  ≤ 50% of the 
nodule volume) ( fig.  1 .8),  mixed predominantly cystic 
(liquid portion >50% but  ≤ 90% of the nodule volume) 
( fig. 1 .9),  cystic (liquid portion >90% of the nodule vol-
ume) ( fig. 1 .10), and  spongiform (more than half of the 
nodule volume characterized by aggregation of multiple 
microcystic areas (<5 mm) separated by thin septations 
that are interspersed within solid tissue) ( fig. 1 .11)  [20] .
 Cystic nodules can be described as  pure cysts (if with-
out internal septa) or as  polyconcamerated cysts (if with 
one or more internal septa); predominantly solid or pre-
dominantly cystic nodule, instead, can also be called  com-
plex nodules . In general, pure cystic lesions are always 
thought to be benign; on the contrary, polyconcamerated 
cysts and complex nodules may harbor a risk of malig-
nancy  [21] . In pure cystic lesions, fluid usually appears 
homogeneously anechoic, with through transmission of 
sound waves and posterior acoustic enhancement. It usu-
ally consists of colloid and sometimes the sound wave in-
teraction with the condensed colloid proteins may result 
in bright hyperechoic reverberation artifacts (i.e.  comet 
tails ) that may be useful in distinguishing the nature of 
the fluid  [22] . A single comet tail artifact within a small 
cyst is usually called  ‘cat’s eye artifact’  [22] . Sometimes, 
the content of some cystic nodules may appear less ho-
mogeneous due to its major density. The fluid content 
should be described as having the  ‘snow falls pattern’ 
when within it, multiple faint hyperechoic spots with 
brownian motion are present. In complex nodules, in-
stead, the fluid component may also be the result of de-
generation or hemorrhage. In these cases, it may change 
over time as the hematoma resolves, appearing isoechoic 
or hypoechoic, sometimes raising doubt as to whether the 
internal content is liquid or solid. Absence of blood flow 
is usually, but not always, helpful in this distinction. In 
the presence of internal solid components, distinguishing 
internal debris from viable tissue, which may present the 
same gray-scale imaging, is very important. In fact, the 
first are usually the result of organization processes, are 
always benign and should not be aspirated for diagnosis. 
On the contrary, the solid component of complex nodules 
composed of viable tissues may harbor a 3% risk of ma-
lignancy  [21] and therefore they require more attention. 
Malignant US features of the solid component of complex 
nodules reported by literature include: an eccentric con-
figuration, microlobulated or irregular free margins, mi-
crocalcifications within a solid component, perinodular 
infiltration, and a centripetal vascularity in the pedicle 
 [23, 24] .
 Finally, a particular mention for the spongiform pat-
tern. It usually appears finely inhomogeneous and it is 
always found in benign hyperplastic nodules. A spongi-
form nodule may relay the overall impression of iso- to 
hyperechogenicity, but it must be distinguished from iso- 
 Fig. 1. US images showing the main features of the thyroid nod-
ules.  1.1 Ovoid nodule deforming thyroid capsule.  1.2 Nodule in-
filtrating thyroid capsule (see interruption of hyperechoic cap-
sule).  1.3 Tumoral nodule invading perithyroidal tissue (see in-
vasion of jugular vein).  1.4 Solid round nodule.  1.5 Markedly 
hypoechoic nodule with ‘taller-than-wide’ shape.  1.6 Large nodule 
with irregular shape.  1.7 Homogeneous, isoechoic, solid nodule 
with well-defined margins and thin halo sign.  1.8 Mixed nodule 
presenting predominantly solid internal content.  1.9 Mixed nod-
ule presenting predominantly cystic internal content.  1.10 An-
echoic pure cystic nodule.  1.11 Spongiform nodule with regular 
margins and finely inhomogeneous echostructure (see internal 
bright hyperechoic spots).  1.12 Hypoechoic nodule.  1.13 Hyper-
echoic nodule.  1.14 Nodule with markedly inhomogeneous echo-
structure.  1.15 Laser-treated nodule with inhomogeneous echo-
structure (see cavitations and hyperechoic scars).  1.16 Nodule 
containing microcalcifications.  1.17 Nodule containing coarse 
macrocalcifications (see posterior acoustic shadow).  1.18 Nodule 
with peripheral ‘eggshell’ calcification.  1.19 Nodule presenting ill-
defined margins.  1.20 Nodule with spiculated margins.  1.21 Nod-
ule presenting microlobulated edges.  1.22 Nodule with thick ir-
regular halo.  1.23 Nodule presenting perinodular flow (PD).  1.24 
Nodule with moderate intranodular flow (PD).  1.25 Nodule with 
moderate peri-intranodular flow (CD).  1.26 Nodule with in-
creased intranodular flow (CD).  1.27 Nodule with increased peri-
intranodular flow (PD).  1.28 US-E evaluation of predominantly 
elastic nodule (see prevalence of ‘soft’ areas within the nodule). 
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or hyperechoic complex nodules with isolated discrete 
cystic areas, because the first are benign and the latter may 
be malignant. Sometimes, spongiform nodules may also 
have hyperechoic foci ( fig.  1 .11) that may be confused 
with microcalcifications. Nevertheless, while in spongi-
form nodules hyperechoic foci are associated with the 
septations or in back wall of the small internal cystic spac-
es, the real microcalcifications, instead, are located within 
the solid stroma itself.
 Echogenicity
 Echogenicity is another important feature to be an-
alyzed in thyroid nodules. The normal thyroid tissue
is homogeneously hyperechoic and brighter than the
surrounding muscles. Although the parenchymal echo-
genicity of thyroid glands can vary greatly among indi-
viduals, the echogenicity of a thyroid nodule should al-
ways be referred to the brightness of its solid component 
in comparison with the thyroid parenchyma  [15, 20] . 
When the solid component of a nodule presents different 
degrees of echogenicity, the overall nodular echogenicity 
should be defined by that of the majority of the nodule.
 Based on echogenicity a thyroid lesion can be classified 
as:  markedly hypoechoic (nodule hypoechoic relative to 
the adjacent strap muscles) ( fig. 1 .5),  hypoechoic (nodule 
hypoechoic relative to the thyroid parenchyma) ( fig. 1 .12), 
 isoechoic (nodule with the same echogenicity as that of the 
thyroid parenchyma) ( fig. 1 .7),  hyperechoic (nodule more 
echoic than thyroid parenchyma) ( fig. 1 .13), and  anecho-
ic (in cystic lesions with fluid content with through trans-
mission of sound waves) ( fig. 1 .10).
 Nodule echogenicity may be challenging to be classi-
fied in two situations: (a) in complex nodules in which the 
cystic area is not clearly distinct from the solid area, and 
(b) in some nodules when extranodular thyroid tissue is 
affected by Hashimoto’s thyroiditis.
 Pure cysts are always benign and appear anechoic. Hy-
poechogenicity, instead, is seldom reported in thyroid ma-
lignancies. Hypoechogenicity is thought to represent a cel-
lular microfollicular histologic milieu, whereas the ultra-
sound appearance of macrofollicular benign nodules is 
usually isoechoic or hyperechoic  [25] . Unfortunately, hy-
poechogenicity may also represent a typical feature of be-
nign nodular fibrosis  [26] and in fact almost a third of be-
nign thyroid lesions are hypoechoic too. On the contrary, 
marked hypoechogenicity seems to be highly specific for 
malignant nodules  [15, 20] . It follows that particular atten-
tion should be placed on markedly hypoechoic lesions.
 Echotexture
 Nodule echotexture plays a marginal role in differen-
tial diagnosis of thyroid lesions. Based on echotexture, 
nodules should be classified as  homogeneous ( fig.  1 .7), 
 finely inhomogeneous ( fig. 1 .11) and  markedly inhomoge-
neous ( fig. 1 .14).
 Although homogeneous nodules are often benign, 
even malignancy cannot be excluded. Similarly, inhomo-
geneous patterns (both finely and markedly), although 
more often observed in malignant nodules, are not exclu-
sive of malignancies being observable in benign lesions 
too. For these reasons, the echotexture is widely recog-
nized as not being a useful finding in distinguishing ma-
lignant from benign lesions  [20] .
 Due to the spread of thermal ablation techniques for 
reducing the size of benign thyroid nodules (e.g. laser, ra-
diofrequency)  [27] , endocrinologists may have to deal 
with US evaluation of previously thermal-treated thyroid 
lesions. Therefore, these nodules deserve a particular 
mention because they appear  markedly inhomogeneous 
and for their peculiar US features that may change over 
time. In fact, immediately after the procedure, hyper-
echoic images due to tissue infiltration by gas may be not-
ed. Peculiar cavitations, surrounded by charring, can be 
also noticed as result of positioning of fibers, especially in 
laser-treated lesions. Months after the treatment, ther-
mal-ablated nodules are usually even more inhomoge-
neous for the presence of avascular hypoechoic necrotic 
areas and scars, as a normal result of thermal ablation 
( fig. 1 .15). Scars appear as hyperechoic areas that can be 
confused with coarse calcifications, which differ because 
of the lack of posterior acoustic shadowing. These nod-
ules should not be confused with malignancy  [28] , but 
their features should always be reported in follow-up US 
reports in order to monitor changes in their characteris-
tics.
 Presence of Calcifications
 Calcifications may occur in up to a third of thyroid, 
both benign and malignant, nodules, and are defined as 
prominent echogenic foci on US, with or without poste-
rior shadowing. Calcifications should be classified in:  mi-
crocalcifications ,  macrocalcifications and  peripheral rim 
calcifications (also called  ‘eggshell’ calcifications ). The 
type of calcification should always be specified in the US 
reports.
 Standardized Ultrasonography of Thyroid 
Nodules 
Eur Thyroid J 2013;2:37–48 
 DOI: 10.1159/000347144 
43
 Microcalcifications appear as small (<1 mm) intra-
nodular punctate hyperechoic spots without posterior 
acoustic shadowing ( fig. 1 .16). Sometimes distinguishing 
microcalcifications from a benign punctuate echogenic 
foci may be difficult (see above). Reverberation artifacts 
due to colloid materials, i.e. comet tails, can be helpful in 
differential diagnosis. Microcalcifications are thought to 
represent the calcified psammoma bodies of papillary 
thyroid cancer and are highly specific for thyroid cancer. 
They are usually within malignant well-defined nodular 
thyroid lesions, but sometimes thyroid papillary carcino-
mas may also appear as a shaded area of grouped micro-
calcifications with no evidence of a clear nodular lesion. 
Microcalcifications should be differentiated from the mi-
crofibrotic hyperintense lesions and dense colloid micro-
deposits.
 Macrocalcifications are coarse and large calcifications 
(>1 mm) that cause posterior acoustic shadowing 
( fig. 1 .17). They occur most frequently in older patients 
or in ‘old’ degenerating benign nodules, representing per-
haps a possible pathologic evolution of some thyroid
lesions  [29] . However, macrocalcifications, especially if 
associated with microcalcifications, within a hypoechoic 
nodule, may be worrisome for malignancy.
 Peripheral rim calcifications (‘eggshell’) may be  com-
plete or  incomplete ( fig. 1 .18). Peripheral eggshell calcifi-
cations surround the thyroid lesion and are thought to 
indicate a benign nodule. However, this has also been re-
ported in malignant nodules  [30] , especially in cases of 
incomplete calcification. In fact, the interruption of the 
rim calcification may indicate probable invasion by the 
cancer. Therefore, outage in peripheral rim calcification 
should always be considered a worrisome finding  [20, 
31] .
 Margins
 The margins of a thyroid nodule should be described 
on the basis of their  definition and their  regularity . It fol-
lows that thyroid nodule edges may appear:  well defined 
(when there is a clear demarcation with normal thyroid 
tissue) ( fig. 1 .7) or  ill defined (lack of clear demarcation 
with normal thyroid parenchyma) ( fig.  1 .19),  regular 
(without irregularities and imperfections) ( fig.  1 .11) or 
 irregular (with edges and irregularities), the latter further 
divided into  spiculated (presence of one or more spicula-
tions on its surface) ( fig. 1 .20) and  microlobulated (pres-
ence of one or more smooth lobules on its surface) 
( fig. 1 .21).
 Ill-defined and irregular, both spiculated and micro-
lobulated, margins are usually reported to be suggestive 
of malignancy  [14, 15] . In fact, malignant nodules may 
present ill-defined margins due to the infiltration of the 
surrounding thyroidal parenchyma. Therefore, irregular 
margins, and most of all microlobulated appearance, are 
findings highly suggestive of malignancy  [20] . Unfortu-
nately, this finding is also reported in benign conditions 
such as thyroiditis  [20] or in some benign thyroid nodules 
incompletely encapsulated that can merge with normal 
tissue  [32] .
 The  halo sign is another US pattern that should be de-
scribed if present. The halo sign appears as a hypoanecho-
ic ring that may completely or incompletely surround a 
nodule. It is comprised of a pseudocapsule formed by fi-
brous connective tissue, compressed thyroid tissue and 
chronic inflammatory change  [33] . It can be a  regular thin 
halo ( fig. 1 .7) or an  irregular thick halo ( fig. 1 .22). The thin 
regular halo, which demonstrates the nodule’s peripheral 
vascularity on color Doppler (CD) or power Doppler 
(PD), is a finding usually suggestive of benign lesion  [34] , 
but more than a half of benign nodules lack a halo  [33] . 
On the other hand, even some papillary carcinomas may 
have a halo  [34–36] . The  thick irregular halo , instead, is 
usually avascular, and may signify the fibrous capsule sur-
rounding a neoplastic growth. Therefore, a thick irregular 
halo may be suggestive of capsular invasion by a cancer 
and it is worthy of special attention  [37] .
 Unfortunately, the definition of nodules’ margins is 
probably the most difficult US feature to be described and 
it is highly operator-dependent. This finding explains the 
high interobserver variability in the definition of margins 
reported by several studies  [38] , but the use of CD and/or 
PD and the increase in expertise of endocrinologists ded-
icated to thyroid US might probably reduce this draw-
back.
 Vascularity
 In nodular goiter, Doppler imaging is used predomi-
nantly to assess the vascularity of nodular tissue. The 
leading use is to help determine the likelihood of a thyroid 
nodule being malignant. Vascularity of a thyroid lesion 
can be evaluated with CD and/or PD imaging. Based 
upon the Doppler effect, CD is a measure of the direc-
tional component of the velocity of blood moving through 
the sample volume. It provides information regarding 
both direction and velocity of blood flow within the nod-
ule, but its shortcomings include the interference by noise 
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and angle dependence. PD analysis, instead, indicates the 
total amount of flow present, without information about 
velocity. PD is more sensitive for detection of flow in 
small vessels that would not be detected by CD. Further-
more, PD imaging is relatively independent of the angle 
of the probe and has less noise interference than CD. 
Therefore, PD should be the preferred imaging technique 
for assessing the vascularity of thyroid nodules  [37] . CD 
and PD are frequently used to differentiate between solid 
thyroid nodules and avascular structures such as a blood 
clots or debris  [10] .
 Several numeric flow-pattern classifications have been 
proposed but, in our opinion, they can be confounding. 
Indeed, we suggest a simply descriptive classification of 
nodule vascularity:  absent (no or scarce blood flow);  peri-
nodular (vascular predominance in the periphery of the 
nodule) ( fig. 1 .23), further divided into  complete or  par-
tial ;  intranodular (vascular predominance within the 
nodule), and  peri-intranodular (flow in the periphery and 
within the nodule). The last two can be further divided by 
PD in two subtypes: (a)  moderate : moderate blood flow 
with homogeneous structure and regular caliber of blood 
vessels ( fig. 1 .24,  1 .25), and (b)  increased : high blood flow 
with anarchical structure with tortuous caliber of vessels 
( fig. 1 .26,  1 .27).
 Most benign nodules have absent or perinodular flow, 
but the new powerful US machines are now effective in 
also highlighting moderate blood flow even in benign le-
sions  [14, 39] . Therefore, presence of vascularity does not 
necessarily indicate a tumor. Most thyroid cancers, in-
stead, present increased vascularity in comparison with 
surrounding parenchyma, but the specificity of this char-
acter is low  [37] . In fact, different investigators have used 
PD in attempts to determine the correlation between 
nodule vascularity and malignant involvement, but the 
results have been inconsistent  [37] . The predictive value 
of blood flow for cancer is reported to be stronger only for 
nodules with cytology of follicular lesions in which the 
absence of vascularity reduces probability of malignancy 
from the generally accepted 20% for unselected ones to 
only 3%  [40, 41] . 
 In conclusion, based on literature  [14, 39] and on our 
experience, nodular vascularity may also be present in up 
to half of benign nodules. We therefore suggest to care-
fully interpret CD and PD flow patterns along with other 
US characteristics as well as clinical features. We do not 
recommend using CD for differential diagnosis of thy-
roid cancer but only to differentiate between solid thyroid 
nodules and avascular structures  [10] .
 Size
 Thyroid nodules should be measured in all their three 
diameters, i.e. anteroposterior, transverse, and longitudi-
nal. When measuring the nodule size, it is advisable to 
locate the calipers at the outer margin of the halo of the 
nodule  [10] .
 The risk of malignancy does not change with the size 
of the nodule  [42, 43] that should be precisely document-
ed only for the purpose of follow-up and not for distin-
guishing a malignant lesion from a benign nodule.
 There has been no clear consensus on the definition of 
nodule growth. We recommend the definition of nodule 
growth as a 20% increase in the nodule diameter (with a 
minimum increase in two dimensions of at least 2 mm) 
or a 50% increase in the nodule volume, according to the 
American Thyroid Association guidelines  [3] . The previ-
ously mentioned criteria of nodular growth permits to 
overcome the reported interobserver’s variability allow-
ing the determination of true change in size  [38, 44] .
 Cystic nodules usually show slower growth than solid 
nodules  [45] . Moreover, although malignancy is believed 
to grow more frequently than benignancy, it should be 
remembered that the majority of benign thyroid nodules 
also grow with time  [46, 47] . Therefore, a growing nodule 
does not necessarily indicate a tumor. On the contrary, 
differentiated thyroid cancers may remain unchanged in 
size for several years. Finally, a very rapid growth of a thy-
roid nodule should raise the suspicion of anaplastic thy-
roid carcinoma, thyroid lymphoma, or medullary thyroid 
carcinoma  [48] .
 Elastosonography: Another Potential Parameter
 Thyroid US is widely recognized as the first-line diag-
nostic procedure for characterizing thyroid lesions  [9] . 
Nevertheless, sometimes, thyroid nodules may require a 
re-evaluation by second-level sonographers for better di-
agnostic characterization. In second-level centers, in fact, 
aside from clinicians particularly skilled in thyroid US, 
there are modern ultrasound machines equipped with 
software specifically developed for ultrasound research. It 
follows that in these centers it may be possible to obtain 
adjunctive information on nodule features. Thyroid nod-
ule hardness, for example, is another feature that could be 
evaluated. Elastosonography (US-E) provides an estima-
tion of tissue stiffness  [49, 50] . Malignant lesions are often 
characterized by greater stiffness than normal tissue  [51] , 
and US-E has been proposed to differentiate cancers from 
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benign thyroid lesions. Results of recent studies seem to 
confirm US-E as a useful non-invasive tool for differential 
diagnosis  [52–57] , although, in our experience and as re-
cently reported by literature  [58] , it seems to have lower 
sensitivity and specificity than that previously reported 
by some authors  [53, 55, 59] . US-E may also play a role in 
differential diagnosis of indeterminate lesions  [60] and in 
distinguishing nodules from pseudonodules in thyroid-
itis  [61] . Unfortunately, US-E cannot be performed on 
partially cystic, calcific or coalescent nodules and its re-
sults should be interpreted with caution in some selected 
patient categories  [62] .
 Many US machines with different software perform-
ing US-E are in commerce at the moment and each one 
presents peculiar characteristics and mode of use. In gen-
eral, the US-E technique combines anatomic B-mode and 
elasticity images. The US-E elastogram is usually dis-
played over the B-mode image in a color scale depending 
on the magnitude of strain, usually red (soft tissue), green 
(intermediate degree of stiffness), and blue (hard, anelas-
tic tissue) ( fig.  1 .28). Based on the overall pattern, the 
nodules can be immediately classified into different class-
es of hardness, hard being lesions more suspicious for 
thyroid cancer. This classification may be affected by a 
certain degree of subjectivity in assigning the grade of 
elasticity. To reduce this variability, classifications based 
on more objective numeric scores have been studied  [63–
65] . Unfortunately, at the moment, the proposed objec-
tive analyses are still too elaborate and time-consuming 
and also require further scientific confirmations. More-
over, it should be remembered that US-E software is not 
sufficiently widespread and therefore cannot be per-
formed routinely yet.
 In conclusion, US-E is a promising tool in the evalua-
tion of thyroid nodules. More objective and immediate 
parameters of hardness are needed to definitely improve 
the diagnostic accuracy of this technique.
 US Classification System
 In some second-level centers, some ultrasonographers 
use a US classification systems for differentiating thyroid 
nodules  [66, 67] as no single US feature of thyroid nod-
ules retains a sufficient predictive value for the suspicion 
diagnosis of thyroid cancer. Some researchers have there-
fore proposed using a combination of features in order to 
improve the US sensitivity and specificity in this field  [14, 
15, 66, 67] . Nevertheless, when multiple patterns sugges-
tive of malignancy are simultaneously present in a nod-
ule, the specificity increases, but the sensitivity becomes 
unacceptably low  [14] . It follows that a combination of 
features can be used only to stratify the risk. Some authors 
have evaluated the diagnostic accuracy of the combina-
tion of different US features and have proposed different 
US classification systems for differentiating thyroid nod-
ules  [68, 69] .
 In our opinion, a standardized US classification sys-
tem, although not achieving the required diagnostic cer-
tainty, may improve the clinical thyroid nodule manage-
ment of endocrinologists dealing with this finding. In 
fact, a standardized US classification system (a) may re-
duce differences in the risk evaluation of a thyroid nodule 
by physicians not directly performing US, (b) may better 
lead the choice of the nodules to be aspirated or to be fol-
lowed up with more attention, and (c) may facilitate data 
comparison in scientific studies.
 Combining current data of literature  [68, 69] with our 
experience, we designed a US classification system of five 
categories based on thyroid nodule US characteristics
and currently used in our center ( table 1 ). Nodular US 
features are divided into:  US features of malignancy  in-
cluding: marked hypoechogenicity, spiculated margins, 
microlobulated margins, microcalcifications, a taller-
than-wide shape, perithyroidal infiltration, perithyroidal 
invasion, and associated metastatic lymphadenopathy; 
 borderline US features including: hypoechogenicity, ir-
regular shape, ill-defined margins, irregular thick halo, 
increased intranodular vascularity, increased peri-intra-
nodular vascularity, macrocalcifications, and partially in-
terrupted rim calcifications, and  US features of benignity 
including: ovoid shape, round shape, isoechogenicity, hy-
perechogenicity, well-defined margins, regular margins, 
regular thin halo, perinodular vascularity, spongiform 
appearance and pure cystic lesion.
 Therefore, by combining the previous US features, 
each thyroid nodule can be tentatively classified as fol-
lows: (1)  Malignant: three or more US characteristics of 
malignancy regardless of the existence of borderline or 
benign US features. In nodules classified as malignant the 
possibility of a benign lesion can be reasonably ruled out. 
(2)  Suspicious for malignancy: less than three US charac-
teristics for malignancy regardless of the existence of bor-
derline or benign US features. In this category the risk of 
malignancy is high, but the possibility of a benign lesion 
cannot be excluded. (3)  Borderline: one or more border-
line US features without US characteristics suggesting 
malignancy regardless of the existence of benign US pat-
terns. This category includes most of all benign nodules 
but also malignant nodules. (4)  Probably benign: two or 
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more US characteristics that suggest a benign nodule (ex-
cept spongiform appearance and pure cystic lesion), with 
no malignancy or borderline US features. Nodules be-
longing to this category have a low risk of malignancy. (5) 
 Benign: nodules with a spongiform appearance or pure 
cystic lesions, with no malignancy or borderline US fea-
tures. In lesions of this category the possibility of a malig-
nant lesion can be reasonably ruled out.
 Thyroid US Limits
 Thyroid US presents some limitations. First of all, US 
is an observer-dependent method. Interobserver differ-
ences are reported, particularly on descriptions of echo-
genicity and border features of thyroid nodules  [38] . Sec-
ond, with the increased accessibility of high-resolution 
US machines, thyroid ultrasound is being performed 
more commonly by physicians different from radiolo-
gists (e.g. endocrinologists, surgeons, general physicians) 
resulting in a further increase of the variability in US re-
ports. An adequate learning curve is advisable to obtain 
more uniformity in US thyroid execution and reporting, 
but no studies have yet examined it for non-radiologist 
physicians. US variability is further increased by the lack 
of a unique, standardized lexicon for the characterization 
of thyroid nodules. Technical limits of thyroid US are 
represented by thyroid nodules extending into subster-
nal, retroclavicular, intrathoracic or retrotracheal loca-
tions that may not be easily imaged with US. Finally, al-
though thyroid US has the advantage of being a non-in-
vasive procedure and of giving immediate information 
about the degree of suspicion of a thyroid lesion, no single 
sonographic feature or combinations of features are ad-
equately sensitive to identify all malignant nodules. It fol-
lows that FNC is required for ultimate diagnosis in any 
case.
 Conclusions
 Thyroid US is the major diagnostic modality for evalu-
ation of thyroid lesions. Nevertheless, there is no clear 
consensus on the standardized terminology to be used in 
thyroid nodule US reports. Moreover, a univocal US clas-
sification system for differential diagnosis of thyroid le-
sions is still lacking.
 An analytic approach in thyroid nodule US reports is 
now even more desirable because of the large number of 
physicians who actually perform US and the increasing 
number of detected thyroid lesions. The proposed ap-
proach may be particularly useful both for clinicians
performing and not directly performing thyroid US in 
immediately and better identifying the nodules (those 
classified as borderline, suspicious of malignancy or ma-
lignant) worthy of further investigations (i.e. fine-needle 
aspiration and cytology), and distinguishing the lesions 
with very low or absent neoplastic risk. In these cases, the 
cytology may be avoided or deferred.
 In summary, we combined data from literature with 
our experiences, and proposed a standardized US lexicon 
for reporting and classifying thyroid nodules which could 
 Table 1.  US features and US classification system with five categories for the suspicion diagnosis of thyroid nodules
 Malignant US features (US-Mal)  Borderline US features (US-Bor)  Benign US features (US-Ben) 
 Marked hypoechogenicity
 Spiculated margins
 Microlobulated margins
 Microcalcifications
 Taller-than-wide shape
 Perithyroidal infiltration
 Perithyroidal invasion
 Metastatic lymphadenopathy 
 Hypoechogenicity
 Irregular shape
 Ill-defined margins
 Irregular thick halo
 Increased intranodular flow
 Increased peri-intranodular flow
 Macrocalcifications
 Interrupted rim calcifications 
 Ovoid shape
 Round shape
 Isoechogenicity
 Hyperechogenicity
 Well-defined margins
 Regular margins
 Regular thin halo
 Perinodular vascularity
 Spongiform appearance
 Pure cystic lesion 
 1 = Malignant: ≥3 US-Mal (regardless of the existence of US-Bor or US-Ben); 2 = Suspicious for malignancy: ≤2 US-Mal (regardless 
of the existence of US-Bor or US-Ben); 3 = Borderline: ≥1 US-Bor without US-Mal (regardless of the presence US-Ben); 4 = Probably 
benign: ≥2 US-Ben (except spongiform appearance and pure cystic lesion), with no US-Mal, and/or US-Bor; 5 = Benign: spongiform 
nodules, pure cystic lesions, without US-Mal and/or US-Bor. 
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improve the management of the patients. Although the 
proposed US classification system still requires a scien-
tific validation, we believe that this proposal can become 
useful for all clinicians dealing with nodular thyroid dis-
ease in their clinical practice.
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